NCT07416890
- Conditions
- Central Nervous System Lymphoma, Pirtobrutinib, Sintilimab
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Clinical trial condition
Pirtobrutinib
Explore clinical trials studying Pirtobrutinib. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Pirtobrutinib trial results
Not yet recruiting
Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL
NCT07744737
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
Not yet recruiting
Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL
NCT07744724
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China